Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ekygard+ is a veterinary nutritional supplement developed by Laboratoires Audevard to provide triple gastric protection for horses. It is formulated as a complementary feed to help manage gastric acidity, preserve the stomach mucosa, and support intestinal flora. The product features the Pectigard Complex®, a proprietary combination of pectin and lecithin that forms a protective gel barrier on the stomach lining. Additional active components include magnesium hydroxide, which acts as an antacid buffer, sea buckthorn berries for mucosal support, and probiotics to maintain a healthy digestive microbiome. It also contains aloe vera for its soothing properties and fenugreek to stimulate appetite in horses suffering from gastric discomfort. Ekygard+ is primarily indicated for sport horses or those prone to gastric sensitivity and ulcers, and it can be used both for active support during risk periods and for long-term preventive maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ekygard+.